[1] Jain S, Williams DJ, Arnold SR, et al. Community-acquired pneumonia requiring hospitalization among U.S. children. N Engl J Med. 2015; 372(9): 835-845.
[2] Principi N, Esposito S, Blasi F, Allegra L, Mowgli study group. Role of Mycoplasma pneumoniae and Chlamydia pneumoniae in children with community-acquired lower respiratory tract infections. Clin Infect Dis. 2001; 32(9): 1281-1289.
[3] Principi N, Esposito S. Emerging role of Mycoplasma pneumoniae and Chlamydia pneumoniae in paediatric respiratory-tract infections. Lancet Infect Dis. 2001; 1(5): 334-344.
[4] Liu JR, Lu J, Dong F, et al. Low Bacterial Co-infection Invalidates the Early Use of Non-anti-Mycoplasma pneumoniae Antibiotics in Pediatric Refractory Mycoplasma pneumoniae Pneumonia Patients. Front Pediatr; 2018. 6: 296.
[5] You SY, Jwa HJ, Yang EA, Kil HR, Lee JH. Effects of Methylprednisolone Pulse Therapy on Refractory Mycoplasma pneumoniae Pneumonia in Children. Allergy Asthma Immunol Res; 2014. 6(1): 22-26.
[6] Lee KY, Lee HS, Hong JH, et al. Role of prednisolone treatment in severe Mycoplasma pneumoniae pneumonia in children. Pediatr Pulmonol. 2006; 41(3): 263-268.
[7] Zhao C, Liu J, Yang H, Xiang L, Zhao S. Mycoplasma pneumoniae-Associated Bronchiolitis Obliterans Following Acute Bronchiolitis. Sci Rep. 2017; 7(1): 8478.
[8] San Martin I, Zarikian SE, Herranz M, Moreno-Galarraga L. Necrotizing pneumonia due to Mycoplasma in children: an uncommon presentation of a common disease. Adv Respir Med; 2018.
[9] Leong MA, Nachajon R, Ruchelli E, Allen JL. Bronchitis obliterans due to Mycoplasma pneumonia. Pediatr Pulmonol. 1997; 23(5): 375-381.
[10] Han X, He B, Wang F. [Mycoplasma pneumonia associated with hemolytic anemia: case report and literature review]. Zhonghua Jie He He Hu Xi Za Zhi. 2011; 34(11): 832-836.
[11] Brown SM, Padley S, Bush A, Cummins D, Davidson S, Buchdahl R. Mycoplasma pneumonia and pulmonary embolism in a child due to acquired prothrombotic factors. Pediatr Pulmonol. 2008; 43(2): 200-202.
[12] Parker P, Puck J, Fernandez F. Cerebral infarction associated with Mycoplasma pneumoniae. Pediatrics. 1981; 67(3): 373-375.
[13] Li T YH, Hou W LZ, Han C WL. Children with MPP have a higher risk of blood coagulation and thrombosis. J Int Med Res. 2017; 46(5): 2110-2118.
[14] Jin X, Zhu Y, Zhang Y, Chen J, Rong L, Zhao X. Assessment of levels of D-dimer and interferon-γ in pediatric patients with Mycoplasma pneumoniae pneumonia and its clinical implication. Exp Ther Med. 2018; 16(6): 5025-5030.
[15] Subspecialty Group of Respiratory Diseases, The Society of Pediatrics, Association CM, Editorial Board, Chinese Journal of Pediatrics. [Guidelines for management of community acquired pneumonia in children (the revised edition of 2013) (I)]. Zhonghua Er Ke Za Zhi. 2013; 51(10): 745-752.
[16] Monagle P, Cuello CA, Augustine C, et al. American Society of Hematology 2018 Guidelines for management of venous thromboembolism: treatment of pediatric venous thromboembolism. Blood Adv. 2018; 2(22): 3292-3316.
[17] Li QR, Yuan Y, Lin L. [Mycoplasma pneumoniae pneumonia complicated with cardiac thrombosis in children: report of 2 cases]. Zhonghua Er Ke Za Zhi. 2018; 56(12): 950-951.
[18] Qiu WL, Wang YS, Chen ZM. [Splenic infarction in a child with Mycoplasma pneumoniae pneumonia]. Zhonghua Er Ke Za Zhi. 2017; 55(9): 705-706.
[19] Antachopoulos C, Liakopoulou T, Palamidou F, Papathanassiou D, Youroukos S. Posterior cerebral artery occlusion associated with Mycoplasma pneumoniae infection. J Child Neurol. 2002; 17(1): 55-57.
[20] Ryu JS, Kim HJ, Sung IY, Ko TS. Posterior cerebral artery occlusion after Mycoplasma pneumoniae infection associated with genetic defect of MTHFR C677T. J Child Neurol. 2009; 24(7): 891-894.
[21] Yoon IA, Hong KB, Lee HJ, et al. Radiologic findings as a determinant and no effect of macrolide resistance on clinical course of Mycoplasma pneumoniae pneumonia. BMC Infect Dis; 2017. 17(1): 402.
[22] Chen L, Liu J, Zhao S, Yang Y, Wu J. [Clinical features and treatment of refractory Mycoplasma pneumoniae pneumonia unresponded to conventional dose methylprednisolone in children]. Zhonghua Er Ke Za Zhi. 2014; 52(3): 172-176.
[23] Liu JR, Peng Y, Yang HM, Li HM, Zhao SY, Jiang ZF. [Clinical characteristics and predictive factors of refractory Mycoplasma pneumoniae pneumonia]. Zhonghua Er Ke Za Zhi; 2012. 50(12): 915-918.
[24] Choi YJ, Jeon JH, Oh JW. Critical combination of initial markers for predicting refractory Mycoplasma pneumoniae pneumonia in children: a case control study. Respir Res. 2019; 20(1): 193.
[25] Kim KW, Sung JJ, Tchah H, et al. Hepatitis associated with Mycoplasma pneumoniae infection in Korean children: a prospective study. Korean J Pediatr; 2015. 58(6): 211-217.
[26] Yang EA, Kang HM, Rhim JW, Kang JH, Lee KY. Early Corticosteroid Therapy for Mycoplasma pneumoniae Pneumonia Irrespective of Used Antibiotics in Children. J Clin Med; 2019. 8(5).
[27] Menéndez R, Martínez R, Reyes S, et al. Biomarkers improve mortality prediction by prognostic scales in community-acquired pneumonia. Thorax. 2009; 64(7): 587-591.
[28] Keller K, Beule J, Balzer JO, Dippold W. D-Dimer and thrombus burden in acute pulmonary embolism. Am J Emerg Med. 2018; 36(9): 1613-1618.
[29] Hochuli M, Duewell S, Frauchiger B. Quantitative d-dimer levels and the extent of venous thromboembolism in CT angiography and lower limb ultrasonography. Vasa. 2007; 36(4): 267-274.
[30] Witmer CM, Steenhoff AP, Shah SS, Raffini LJ. Mycoplasma pneumoniae, splenic infarct, and transient antiphospholipid antibodies: a new association. Pediatrics. 2007; 119(1): e292-295.
[31] Nagashima M, Higaki T, Satoh H, Nakano T. Cardiac thrombus associated with Mycoplasma pneumoniae infection. Interact Cardiovasc Thorac Surg. 2010; 11(6): 849-851.
[32] Hsieh YC, Wang CW, Lai SH, et al. Necrotizing pneumococcal pneumonia with bronchopleural fistula among children in Taiwan. Pediatr Infect Dis J. 2011; 30(9): 740-744.
[33] Snowden N, Wilson PB, Longson M, Pumphrey RS. Antiphospholipid antibodies and Mycoplasma pneumoniae infection. Postgrad Med J. 1990; 66(775): 356-362.
[34] Padovan CS, Pfister HW, Bense S, Fingerle V, Abele-Horn M. Detection of Mycoplasma pneumoniae DNA in cerebrospinal fluid of a patient with M. pneumoniae infection-"associated" stroke. Clin Infect Dis. 2001; 33(10): E119-121.
[35] Takahashi I, Ishihara M, Oishi T, Yamamoto M, Narita M, Fujieda M. Common carotid arteritis and polymyalgia with Mycoplasma pneumoniae infection. J Infect Chemother. 2019; 25(4): 281-284.
[36] Wynants M, Quarck R, Ronisz A, et al. Effects of C-reactive protein on human pulmonary vascular cells in chronic thromboembolic pulmonary hypertension. Eur Respir J. 2012; 40(4): 886-894.
[37] Versteeg HH, Heemskerk JW, Levi M, Reitsma PH. New fundamentals in hemostasis. Physiol Rev; 2013. 93(1): 327-358.
[38] Middleton EA, Weyrich AS, Zimmerman GA. Platelets in Pulmonary Immune Responses and Inflammatory Lung Diseases. Physiol Rev; 2016. 96(4): 1211-1259.
[39] Lefrançais E, Ortiz-Muñoz G, Caudrillier A, et al. The lung is a site of platelet biogenesis and a reservoir for haematopoietic progenitors. Nature. 2017; 544(7648): 105-109.
[40] Zaidi AU, Hutchins KK, Rajpurkar M. Pulmonary Embolism in Children. Front Pediatr. 2017; 5: 170.